Madrigal Pharmaceuticals | 4:持股变动声明-董事 CRAVES FRED B
Madrigal Pharmaceuticals | 144:拟议出售证券
Madrigal Pharmaceuticals | S-3ASR:“知名成熟发行人”证券注册声明
Madrigal Pharmaceuticals | 424B3:募资说明书
Madrigal Pharmaceuticals | 8-K:重大事件
Madrigal Pharmaceuticals | 424B5:募资说明书
Madrigal Pharmaceuticals | 10-Q:季度报表
Madrigal Pharmaceuticals | 8-K:Madrigal Pharmicals公布2024年第一季度财务业绩并提供公司最新情况
Madrigal Pharmaceuticals | ARS:年度报告
Madrigal Pharmaceuticals | DEFA14A:其他
Madrigal Pharmaceuticals | DEF 14A:股东委托书决议
Madrigal Pharmaceuticals | 4:持股变动声明-高管 Taub Rebecca
Madrigal Pharmaceuticals | 4:持股变动声明-董事 FRIEDMAN PAUL A
Madrigal Pharmaceuticals | 4:持股变动声明-高管 Taub Rebecca
Madrigal Pharmaceuticals | 4:持股变动声明-董事 FRIEDMAN PAUL A
Madrigal Pharmaceuticals | 4:持股变动声明-董事 Levy Richard S
Madrigal Pharmaceuticals | 4:持股变动声明-董事 BATE KENNETH
Madrigal Pharmaceuticals | 4:持股变动声明-董事 Daly James M
Madrigal Pharmaceuticals | 144:拟议出售证券
Madrigal Pharmaceuticals | 144:拟议出售证券
暂无数据